Dr. Reddy's Laboratories

RDY

Market cap $10.4B

RDY Hedge Fund Activity: Q1 2026 in Review

247 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2026, worth a combined $1.67B — up 11% from $1.5B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new RDY positions and 25 closed out — a net gain of 16 holders — while 102 added to existing stakes and 64 trimmed.

The largest buyer was Robeco Institutional Asset Management, adding an estimated $56M. The largest seller was JP Morgan Chase, cutting an estimated $15.3M.

• 247 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2026, up from 235 in Q4 2025.
• Funds reported $1.67B of Dr. Reddy's Laboratories stock for Q1 2026, up 11% quarter-over-quarter.
• 41 funds opened new Dr. Reddy's Laboratories positions in Q1 2026 and 25 closed out, a net change of +16 holders.
• The largest Dr. Reddy's Laboratories buyer in Q1 2026 was Robeco Institutional Asset Management, an estimated $56M added.
• The largest Dr. Reddy's Laboratories seller in Q1 2026 was JP Morgan Chase, an estimated $15.3M sold.

Based on aggregated 13F filings for Q1 2026.